about
sameAs
Heparin for the prevention of intraventricular haemorrhage in preterm infantsLutein and zeaxanthin for reducing morbidity and mortality in preterm infantsProtocolized versus non-protocolized weaning for reducing the duration of invasive mechanical ventilation in newborn infantsAntithrombin for the prevention of intraventricular hemorrhage in very preterm infantsFrequency of endotracheal suctioning for the prevention of respiratory morbidity in ventilated newbornsHigh flow nasal cannula for respiratory support in preterm infantsTranscutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortalityNeedle aspiration versus intercostal tube drainage for pneumothorax in the newbornPharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infantsFrequency of endotracheal suctioning for the prevention of respiratory morbidity in ventilated newbornsTranscutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortalityAntithrombin for the prevention of intraventricular hemorrhage in very preterm infantsOverview of ventilation strategies for the early management of intubated preterm infantsParacetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infantsBeta-blockers for prevention and treatment of retinopathy of prematurity in preterm infantsPentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infantsNeedle aspiration versus intercostal tube drainage for pneumothorax in the newbornHeparin for the prevention of intraventricular hemorrhage in very preterm infantsProtocolized versus non-protocolized weaning for reducing the duration of invasive mechanical ventilation in newborn infantsVasopressin and its analogues for the treatment of refractory hypotension in neonatesLate (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infantsSystemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infantsPentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infantsVasopressin and its analogues for the treatment of refractory hypotension in neonatesFlow-cycled versus time-cycled synchronized ventilation for neonatesInterventions for prevention of neonatal hyperglycemia in very low birth weight infantsInterventions for treatment of neonatal hyperglycemia in very low birth weight infantsInterventions for prevention of neonatal hyperglycemia in very low birth weight infantsIntra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newbornsIntra-amniotic surfactant for women at risk of preterm birthInterventions for treatment of neonatal hyperglycemia in very low birth weight infantsFlow-cycled versus time-cycled synchronized ventilation for neonatesRestricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infantsInterventions for treatment of neonatal hyperglycemia in very low birth weight infantsInterventions for prevention of neonatal hyperglycemia in very low birth weight infantsVolume-targeted versus pressure-limited ventilation in the neonateOptimum oxygen therapy in preterm babiesCalcineurin/Nfat signaling is required for perinatal lung maturation and functionGlutamine-enriched enteral nutrition in very low birth weight infants. Design of a double-blind randomised controlled trial [ISRCTN73254583]Interleukin-4 and 13 concentrations in infants at risk to develop Bronchopulmonary Dysplasia
P2860
Q24185786-2779821F-7961-47D4-8D63-5F7B186BF6ACQ24185832-50ABD48F-CA85-4DD7-848A-A1495645AE24Q24186017-26C96C1E-F6D8-4B9C-ACE4-5B19288BFD25Q24186020-1A446FE5-67A6-4D9E-A813-C0FD85ADCAE5Q24186043-50CE176F-0645-4D0C-AE2F-E307C274CD74Q24186112-B6A82069-0235-461F-9A84-DBB29E340E0DQ24186139-9FEB51FA-FD1B-4383-B06D-03CD8DE4BA89Q24186527-85A0DB65-FB7C-4CDA-A070-75F32C4FFEE1Q24186815-E221F98C-67FD-438D-A5F4-C73365BA45F7Q24186845-F5678E79-6BCC-4F4B-86CC-BD0765C4FBDCQ24186849-08642E0B-904D-419C-A89D-E976038A28BAQ24186911-3554E6E3-1E25-41A1-B6E3-11694ACDD99AQ24186988-2070F09B-ED38-4D36-AB30-2EE193BC53A0Q24187317-00E996E0-BA1A-4FEE-B92D-661C533F5274Q24187442-D2766DC1-8AAC-4E7C-86CD-86EE69A8EFD3Q24187852-10759C36-5689-421F-B604-A3CBF35D207BQ24188151-D9FE28A8-062C-486B-A9EB-AFF5E1EE67D7Q24188179-BB0CD0F3-5273-4EDD-9CB3-D8401972FEA3Q24194885-F9E9C347-2EFF-4C88-89A0-326FA3FF6C01Q24200218-79B05779-8C95-406D-A4C5-9D24C052FD76Q24200447-03CEC20F-B416-4CDC-90E7-51E82BCB5554Q24201323-3A062AD6-AC27-442B-B97C-8D03D32696A2Q24201869-013F89EC-9FE9-47CE-9C11-38D1AF3A365CQ24233995-DF0C5A91-29D4-414F-922E-4644B8081126Q24234316-E6113442-C961-45C1-BC4D-D5096B880625Q24235946-268591E1-8B6C-4D42-A0FA-690F85BCFD03Q24236299-646DD6FE-5EED-4584-AE52-AECD4853044EQ24239958-FA9419E8-78FB-4AFA-99FC-52ED9E23F47CQ24240793-EA3FA4C4-6990-461C-AA14-BF709129BCF9Q24240886-C2A1104E-C865-4668-B760-1A0339157A7CQ24241103-429076E1-74A1-4224-B99B-16DEBD6D899DQ24241774-8C29888D-A63E-48EB-8BD5-58673941AE76Q24241782-447F55AC-6532-4448-A3DB-59E695843B19Q24242075-88984193-3B9F-481A-8D47-7A6D6C31EA10Q24242113-7847850C-FF55-4F7D-ABED-64FE9FB6311FQ24246562-2F19275C-6C33-4F2E-956B-9C4718FF2346Q24652401-90D63A00-CE95-4333-97BA-8165AEECCABDQ24676318-D72EAC0C-FE5E-447B-9175-03079EC4D0E7Q24792606-583ADA18-D354-4D1B-92E7-7AD2B7D29AA2Q24799521-DB6EB24D-7815-40FF-A324-D134395FEAFB
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Bronchopulmonary dysplasia
@ast
Bronchopulmonary dysplasia
@en
Bronchopulmonary dysplasia
@nl
type
label
Bronchopulmonary dysplasia
@ast
Bronchopulmonary dysplasia
@en
Bronchopulmonary dysplasia
@nl
prefLabel
Bronchopulmonary dysplasia
@ast
Bronchopulmonary dysplasia
@en
Bronchopulmonary dysplasia
@nl
P3181
P1476
Bronchopulmonary dysplasia
@en
P2093
P304
P3181
P356
10.1164/AJRCCM.163.7.2011060
P407
P577
2001-06-01T00:00:00Z